Our analysis revealed a significant correlation between APOC1 expression levels and various clinical features associated with PCa progression, including PFI, pathological stage, primary treatment outcome, tumour residue, Gleason score, and lymph node metastasis, indirectly suggesting a close relationship between APOC1 and PCa metastasis. This evidence concerns the gene APOC1 and neoplasm.